uveitis


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

u·ve·i·tis

 (yo͞o′vē-ī′tĭs)
n.
Inflammation of the uvea.

uveitis

(ˌjuːvɪˈaɪtɪs)
n
(Pathology) inflammation of the uvea
uveitic adj

u•ve•i•tis

(ˌyu viˈaɪ tɪs)

n.
inflammation of the uvea.
[1840–50]

uveitis

an inflamed condition of the uvea. — uveitic, adj.
See also: Eyes
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.uveitis - inflammation of the uvea of the eye
inflammation, redness, rubor - a response of body tissues to injury or irritation; characterized by pain and swelling and redness and heat
Translations

u·ve·i·tis

n. uveítis, infl. de la úvea.

uveitis

n uveítis f
Mentioned in ?
References in periodicals archive ?
XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension), formerly known as CLS-TA, is a proprietary suspension of the corticosteroid triamcinolone acetonide formulated for administration to the back of the eye for the treatment of macular edema associated with uveitis. Clearside's patented technology is designed to deliver drug to the suprachoroidal space located between the choroid and the outer protective layer of the eye, known as the sclera.
His methods included a physician survey of injection experience, and a post-hoc analysis of two Clearside clinical trials for non-infectious uveitis. Injection survey results revealed little difficulty in following the steps in the procedure and generally no challenges compared to other types of injections.
M2 EQUITYBITES-June 7, 2019-Palatin Technologies awarded FDA's orphan drug designation for PL-8177 for treatment of non-infectious uveitis
Global Banking News-June 7, 2019-Palatin Technologies awarded FDA's orphan drug designation for PL-8177 for treatment of non-infectious uveitis
M2 PHARMA-June 7, 2019-Palatin Technologies awarded FDA's orphan drug designation for PL-8177 for treatment of non-infectious uveitis
The owl was diagnosed with bilateral anterior uveitis and a corneal ulceration in the left eye.
A slit lamp examination of the eyes was performed and a thorough search for uveitis were carried out.
As it dissolves, the lens releases medicine to treat uveitis or inflammation of the uvea, which is the vascular layer of the eye.
Uveitis, which is defined as intraocular inflammation, predominantly affects the working-age population (20 to 50 years old) and leads to substantial individual and socio-economic burdens.
The eye is made up of three layers and uveitis is inflammation of the middle layer called the uvea, which makes up the iris and produces the fluid that keeps the eyeball spherical.